- Home
- GV vs GOVX Comparison
GV vs GOVX Comparison
Compare GV & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- GOVX
- Stock Information
- Founded
- GV 2013
- GOVX 2001
- Country
- GV Canada
- GOVX United States
- Employees
- GV N/A
- GOVX N/A
- Industry
- GV Other Consumer Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- GOVX Health Care
- Exchange
- GV Nasdaq
- GOVX Nasdaq
- Market Cap
- GV 7.8M
- GOVX 7.6M
- IPO Year
- GV 2022
- GOVX N/A
- Fundamental
- Price
- GV $1.74
- GOVX $0.69
- Analyst Decision
- GV
- GOVX Strong Buy
- Analyst Count
- GV 0
- GOVX 5
- Target Price
- GV N/A
- GOVX $12.40
- AVG Volume (30 Days)
- GV 61.8K
- GOVX 3.3M
- Earning Date
- GV 08-14-2025
- GOVX 08-05-2025
- Dividend Yield
- GV N/A
- GOVX N/A
- EPS Growth
- GV N/A
- GOVX N/A
- EPS
- GV N/A
- GOVX N/A
- Revenue
- GV $7,773,905.00
- GOVX $5,591,576.00
- Revenue This Year
- GV N/A
- GOVX N/A
- Revenue Next Year
- GV N/A
- GOVX N/A
- P/E Ratio
- GV N/A
- GOVX N/A
- Revenue Growth
- GV N/A
- GOVX N/A
- 52 Week Low
- GV $1.00
- GOVX $0.43
- 52 Week High
- GV $9.60
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- GV 45.53
- GOVX 42.50
- Support Level
- GV $1.61
- GOVX $0.60
- Resistance Level
- GV $2.00
- GOVX $0.77
- Average True Range (ATR)
- GV 0.17
- GOVX 0.09
- MACD
- GV 0.01
- GOVX -0.01
- Stochastic Oscillator
- GV 55.27
- GOVX 47.27
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.